Skip to content

Vascular Changes in Pre-Eclamptic Patients and Its Impact on Pregnancy Outcome.

Assessment ofMaternal and FetalVascular Changes inNormotensive andPre-Eclamptic Patients and Its Impact on Pregnancy Outcome.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03111576
Acronym
PE
Enrollment
100
Registered
2017-04-13
Start date
2017-05-31
Completion date
2021-12-31
Last updated
2021-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-Eclampsia

Brief summary

Normal pregnancy is associated with vasodilation and decreased peripheral resistance, which is detected as early as 5 weeks' gestation . Pre-eclampsia is a multi-system disorder of the second half of pregnancy , which is characterized by increased vascular reactivity and peripheral resistance with pathological changes that are consistent with impaired blood flow to the affected vascular beds. Investigators will evaluate fetal and maternal vascular changes in normotensive and pre-eclamptic patients by Ultrasound and Doppler and their impact on prediction of pregnancy outcome.

Detailed description

Pre-eclampsia affects 2-8% of all pregnancies, although treatment is generally effective. However, 10-15% of direct maternal deaths are associated with Pre-eclampsia and eclampsia(WHO, 2011). There is a considerable evidence that generalized endothelial dysfunction underlies the clinical manifestations of the disease (Oladipupo et al., 2014). It has been demonstrated that peripheral nutritive blood flow is impaired in pregnancies complicated by pre-eclampsia and precedes onset of the disorder (Kenny et al., 2014). The pathophysiological mechanism is characterized by a failure of the trophoblastic invasion of the spiral arteries which may be associated with an increased vascular resistance of the uterine artery and a decreased perfusion of placenta. (Al-Jameil et al ; 2014 ) Ultrasound of the brachial artery, and Doppler ultrasound of the carotid artery and uterine artery are propaedeutic , non-invasive methods that contribute to the understanding of the pathophysiology of PE and Eclampsia (Takata et al., 2002 ). Doppler assessment of the placental circulation plays an important role in screening for impaired placentation and its complications of preeclampsia, intrauterine growth restriction and perinatal death. Assessment of the fetal circulation is essential in the better understanding of the pathophysiology of a wide range of pathological pregnancies and their clinical management(Ghidini & Vergani, 2012).

Interventions

None listed

Sponsors

Beni-Suef University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

1. All women will be : * Nonsmokers, * Nondiabetic, * With no family history of vascular diseases. 2. Gestational age at enrolment \>28 and \<34 weeks of gestation. 3. Singleton pregnancy. 4. Informed consent. 5. 50 Normotensive pregnant women without complications will be defined as controls. 6. 50 Pre-eclamptic patients.

Exclusion criteria

* 1\. Patients who presented to labor and delivery were excluded as subjects. 2. Growth-restricted fetus due to: * marginal insertion of the umbilical cord, * placental infarction, * fetal minor heart anomaly, * Fetal viral infection. 3. Refusal of patient to participate in the study. 4. Multiple gestations. 5. Autoimmune diseases 6. Previous history of PE or IUGR.

Design outcomes

Primary

MeasureTime frameDescription
Vascular changes by Doppler imaging>28-<34 weeksDoppler imaging will be undertaken for assessing fetal umbilical, middle cerebral arteries in addition to ductus venosus. Concerning maternal vessel assessment, Doppler will be done for uterine arteries, common carotid and brachial arteries.

Secondary

MeasureTime frameDescription
Pregnancy outcomeDate of delivery and within 40 days after deliveryMaternal delivery mode and any complications together with fetal growth restriction or neonatal complications.

Countries

Egypt

Contacts

Primary ContactNesreen A Shehata, MD
nesoomar@yahoo.com00201024150605
Backup ContactHamada A Abd el Wahed, MD
hamadaashry2010@yahoo.com01007240754

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026